Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis

Clinical trial NCT01500551 · COMPLETED

Trial details

NCT number: NCT01500551
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Juvenile Idiopathic Arthritis

Start date: 2013-03-18
Primary completion: 2025-02-12
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.